panitumumab
Showing 26 - 50 of 135
Squamous Cell Carcinoma, Adenocarcinoma, Esophageal Cancer Trial in Amsterdam (Carboplatin, Paclitaxel, panitumumab)
Completed
- Squamous Cell Carcinoma
- +3 more
- Carboplatin
- +3 more
-
Amsterdam, NetherlandsAcademic Medical Center
Apr 19, 2021
Colorectal Cancer Metastatic Trial in Spain (Panitumumab, Irinotecan, Folinic acid)
Active, not recruiting
- Colorectal Cancer Metastatic
- Panitumumab
- +3 more
-
Gerona, Barcelona, Spain
- +17 more
Jun 29, 2021
Metastatic Colorectal Cancer Trial in Benevento, Napoli, S. Giovanni Rotondo (Panitumumab)
Active, not recruiting
- Metastatic Colorectal Cancer
- Panitumumab
-
Benevento, BN, Italy
- +4 more
Mar 3, 2021
Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Houston (Carboplatin,
Recruiting
- Stage I Breast Cancer AJCC v7
- +10 more
- Carboplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 12, 2022
Colorectal Cancer Trial in Durham (Panitumumab, Cabozantinib)
Completed
- Colorectal Cancer
- Panitumumab
- Cabozantinib
-
Durham, North CarolinaDuke Cancer Center, Duke University Medical Center
Feb 9, 2021
Colorectal Cancer, Liver Metastases, Colorectal Adenocarcinoma Trial run by the NCI (device, drug, procedure)
Recruiting
- Colorectal Cancer
- +4 more
- Codman 3000 constant flow pump catheter
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
New Prognostic Score for Adult RAS Wild-type mCRC Treated With
Active, not recruiting
- Metastatic Colorectal Cancer
- RAS Wild-type
- Panitumumab
-
Freiburg, Baden-Württemberg, GermanyPraxis für interdisziplinäre Onkologie & Hämatologie
Jul 29, 2022
BRAF V600E Negative, KRAS Gene Mutation Negative, Locally Advanced Unresectable Colorectal Adenocarcinoma Trial in United States
Recruiting
- BRAF V600E Negative
- +12 more
- Cetuximab
- +3 more
-
Scottsdale, Arizona
- +15 more
Aug 23, 2022
Colorectal Tumors, Colorectal Carcinoma, Colorectal Cancer Metastatic Trial in Spain (Panitumumab, Irinotecan, Folinic acid)
Completed
- Colorectal Neoplasms
- +3 more
- Panitumumab
- +3 more
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +11 more
Jun 18, 2021
Advanced Colorectal Cancer Trial in Cyprus, Greece (Panitumumab)
Terminated
- Advanced Colorectal Cancer
- Panitumumab
-
Strovolos, Nicosia, Cyprus
- +7 more
Jun 2, 2021
Metastatic Colorectal Cancer Trial in Worldwide (MEK162, Panitumumab)
Completed
- Metastatic Colorectal Cancer
- MEK162
- Panitumumab
-
Los Angeles, California
- +7 more
Jan 27, 2021
Infiltrating Urothelial Carcinoma, KRAS Gene Mutation Trial in France (Chemotherapy, Panitumumab)
Completed
- Infiltrating Urothelial Carcinoma
- KRAS Gene Mutation
- Chemotherapy
- Panitumumab
-
Bordeaux, France
- +16 more
Mar 4, 2021
Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)
Completed
- Colon Cancer
- +3 more
- Panitumumab
- +2 more
-
Birmingham, Alabama
- +94 more
Nov 10, 2022
Malignant Tumor of Esophagus, Malignant Tumor of Stomach Trial in Villejuif (Oxaliplatin, Folinic Acid, 5-fluoro-uracil)
Completed
- Malignant Neoplasm of Esophagus
- Malignant Neoplasm of Stomach
- Oxaliplatin
- +4 more
-
Villejuif, FranceInstitut Gustave Roussy
Nov 13, 2020
Metastatic Colorectal Cancer Trial in Worldwide (Cetuximab, Panitumumab)
Completed
- Metastatic Colorectal Cancer
- Cetuximab
- Panitumumab
-
Stockton, California
- +151 more
Sep 8, 2022
Metastatic Colorectal Cancer Trial in Vancouver, Ottawa, Toronto (BKM120, Panitumumab)
Completed
- Metastatic Colorectal Cancer
- BKM120
- Panitumumab
-
Vancouver, British Columbia, Canada
- +2 more
Apr 6, 2020
Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,
Active, not recruiting
- Castration-resistant Prostate Cancer
- +2 more
- SM08502
- +5 more
-
Tucson, Arizona
- +19 more
Oct 18, 2022
Gastrointestinal Cancer Trial in Houston (Panitumumab)
Completed
- Gastrointestinal Cancer
- Panitumumab
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 20, 2020
Colorectal Adenocarcinoma, RAS Wild Type, Stage III Colorectal Cancer AJCC v7 Trial in Los Angeles (biological, drug, other)
Terminated
- Colorectal Adenocarcinoma
- +8 more
- Panitumumab
- +6 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Jun 8, 2020
Cancer Trial in Madison (Panitumumab)
Terminated
- Cancer
- Panitumumab
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Nov 19, 2019